Results 121 to 130 of about 48,772 (164)

CXCR4-modification enhances CAR-T efficacy by improving tumor tracking and bone marrow homing in B-cell malignancies. [PDF]

Signal Transduct Target Ther
Shu P, Guo F, Qin D, Zou L, Ma Q, Zhang B, Gao G, Chen Y, He X, Jiang M, Liu N, Zhou K, Zhao J, Lei Y, Gao Y, Zhang Y, Zeng Y, Feng M, Li X, Li D, Wang Y.   +20 more
europepmc   +1 more source

The CXCL12/CXCR4 Axis in Sepsis-Induced Acute Lung Injury: Mechanisms and Therapeutic Potential. [PDF]

Curr Issues Mol Biol
Luo R, Fan Q, Chen Q, Nie Z, Dan L, Xie S.   +5 more
europepmc   +1 more source

Chemokines and their receptors in oral squamous cell carcinoma: mechanisms, clinical significance, and therapeutic implications. [PDF]

Front Immunol
Li D, Chen S, Ji J, Wang Z, Zhou H, Liao Z, Tang Q.   +6 more
europepmc   +1 more source

Initiation of Tertiary Lymphoid Structures for Cancer Immunotherapy. [PDF]

Research (Wash D C)
Zou JY, Li ZT, Wang ZC, Li H, Sun ZJ.
europepmc   +1 more source

Multimodal Spatial Transcriptomics Reveals the Developing Human Liver Niche at Single-Cell Resolution. [PDF]

Gastro Hep Adv
Bailey M, Leon M, Rosso I, Sangokoya C.
europepmc   +1 more source

Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy. [PDF]

Cell Oncol (Dordr)
Nasir Kansestani A, Zare ME, Zhang J.
europepmc   +1 more source

Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies. [PDF]

Nat Commun
Perez Almeria CV, Otun O, Schlimgen R, Lamme TD, Di Niro L, Crudden C, Bebelman JP, Youssef N, Musli L, Jenjak S, Bobkov V, Drube J, Hoffmann C, Volkman BF, Granier S, Bechara C, Siderius M, Heukers R, Schafer CT, Smit MJ.   +19 more
europepmc   +1 more source

Identification of CXCL12 as a key gene of trophoblast and endometrial stromal cell decidualization in pregnancy via scRNA-seq and experimental validation. [PDF]

Front Mol Biosci
Sun X, Yang H, Leng Z, Zhang W, Jiang Z, Liu H.   +5 more
europepmc   +1 more source

CCR2 improves tumor directed CAR-T cell trafficking in ovarian cancer. [PDF]

Front Pharmacol
Kumar R, Veillard IE, Xu M, Al-Alem L, Rueda BR, Yeku OO.   +5 more
europepmc   +1 more source